Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RI0114
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RI0114 |
| Description | This cell line is engineered to overexpress human KCNJ1. |
| Background | Kir1.1 is an inwardly rectifying potassium channel expessed in kidney, skeletal muscle, liver, pancreas, spleen, and the central nervous system. Mutations in Kir1.1 are responsible for Bartter"s syndrome (renal salt loss) and hereditary hypertension with hyperkalemia. Kir1.1 has therapeutic potential in treatment of hypertension. |
| Target Gene | KCNJ1 |
| Gene Species | Homo sapiens (Human) |
| Abbr | HEK293-HuKCNJ1 |
| Alias | KCNJ1, Kir1.1, ROMK1, ROMK, KIR1.1 |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Channelopathies research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Morphology | Epithelial |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | KCNJ1 potassium inwardly-rectifying channel, subfamily J, member 1 [ Homo sapiens ] |
| Gene Symbol | KCNJ1 |
| Synonyms | ROMK; ROMK1; KIR1.1 |
| Gene Description | potassium inwardly-rectifying channel, subfamily J, member 1 |
| Gene ID | 3758 |
| Uni Prot ID | P48048 |
| m RNA Refseq | NM_153764.1 |
| Protein Refseq | NP_722448.1 |
| Chromosome Location | 11q24 |
| Function | ATP binding; inward rectifier potassium channel activity; |
| Pathway | Aldosterone-regulated sodium reabsorption, organism-specific biosystem; Aldosterone-regulated sodium reabsorption, conserved biosystem; Gastric acid secretion, organism-specific biosystem; Gastric acid secretion, conserved biosystem; Inwardly rectifying K+ channels, organism-specific biosystem; Neuronal System, organism-specific biosystem; Potassium Channels, organism-specific biosystem; |
| MIM | 600359 |
A: It can be used to study the role of KCNJ1 in cardiac cells, particularly in understanding the molecular mechanisms of arrhythmias and heart failure.
A: Ensure data accuracy and reproducibility through standardized experimental procedures and conditions, as well as by conducting multiple replicates.
A: As KCNJ1 also functions in the nervous system, this cell line can be used to model and study neurological diseases related to potassium channels.
A: Drugs that may affect the activity of the KCNJ1 channel, including those that regulate potassium ion permeability and potential, should be considered.
A: Since KCNJ1 plays a significant role in regulating potassium balance in the kidneys, this cell line is particularly suitable for studying renal diseases such as Bartter syndrome.
A: The cell line was constructed by stably integrating the human KCNJ1 gene (potassium channel subfamily J member 1) into the genome of HEK293 cells using gene-editing technologies like CRISPR/Cas9.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.